276 related articles for article (PubMed ID: 21792729)
1. MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.
Treglia G; Cason E; Stefanelli A; Cocciolillo F; Di Giuda D; Fagioli G; Giordano A
Clin Auton Res; 2012 Feb; 22(1):43-55. PubMed ID: 21792729
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.
Treglia G; Stefanelli A; Cason E; Cocciolillo F; Di Giuda D; Giordano A
Clin Neurol Neurosurg; 2011 Dec; 113(10):823-9. PubMed ID: 21962800
[TBL] [Abstract][Full Text] [Related]
3. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.
Orimo S; Suzuki M; Inaba A; Mizusawa H
Parkinsonism Relat Disord; 2012 Jun; 18(5):494-500. PubMed ID: 22321865
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis.
Treglia G; Cason E
J Neuroimaging; 2012 Apr; 22(2):111-7. PubMed ID: 21091814
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity and specificity of cardiac
Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Tamura S; Nakazato M; Yamashita S; Arita H; Nishii R; Kawai K
Ann Nucl Med; 2008 Aug; 22(7):557-64. PubMed ID: 18756357
[TBL] [Abstract][Full Text] [Related]
8. Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses.
Lamotte G; Morello R; Lebasnier A; Agostini D; Defer GL
BMC Neurol; 2015 May; 15():83. PubMed ID: 25971430
[TBL] [Abstract][Full Text] [Related]
9. Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?
Stathaki M; Koukouraki S; Simos P; Boura I; Papadaki E; Bourogianni O; Tsaroucha A; Kapsoritakis N; Mitsias P; Spanaki C
Clin Nucl Med; 2020 Aug; 45(8):588-593. PubMed ID: 32404715
[TBL] [Abstract][Full Text] [Related]
10. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases.
Treglia G; Cason E; Gabellini A; Giordano A; Fagioli G
Neurol Sci; 2010 Aug; 31(4):417-22. PubMed ID: 20221656
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
King AE; Mintz J; Royall DR
Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
[TBL] [Abstract][Full Text] [Related]
13. Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.
Uchiyama Y; Momose M; Kondo C; Kusakabe K; Uchiyama S
Ann Nucl Med; 2011 Aug; 25(7):478-85. PubMed ID: 21499991
[TBL] [Abstract][Full Text] [Related]
14. Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease.
Watanabe M; Takeda T; Nakamagoe K; Tamaoka A
Eur J Neurol; 2011 Jul; 18(7):1010-3. PubMed ID: 21658161
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach.
Südmeyer M; Antke C; Zizek T; Beu M; Nikolaus S; Wojtecki L; Schnitzler A; Müller HW
J Nucl Med; 2011 May; 52(5):733-40. PubMed ID: 21498527
[TBL] [Abstract][Full Text] [Related]
16. Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study.
Xu D; Zhu W; Huo L; Zhu S; Li F; Wang H
Parkinsonism Relat Disord; 2018 May; 50():69-73. PubMed ID: 29475590
[TBL] [Abstract][Full Text] [Related]
17. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
Yoshita M; Taki J; Yokoyama K; Noguchi-Shinohara M; Matsumoto Y; Nakajima K; Yamada M
Neurology; 2006 Jun; 66(12):1850-4. PubMed ID: 16801649
[TBL] [Abstract][Full Text] [Related]
18. Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes.
Ryu DW; Kim JS; Lee JE; Oh YS; Yoo SW; Yoo IR; Lee KS
Clin Nucl Med; 2019 Apr; 44(4):282-288. PubMed ID: 30589669
[TBL] [Abstract][Full Text] [Related]
19. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
[TBL] [Abstract][Full Text] [Related]
20. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
Rascol O; Schelosky L
Mov Disord; 2009; 24 Suppl 2():S732-41. PubMed ID: 19877202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
